Reported 2 days ago
Morgan Stanley has upgraded HCA Healthcare's price target from $355 to $410 while keeping an Equal Weight rating. Analyst Craig Hettenbach highlighted HCA's strong performance, with notable growth in admissions and revenue in Q1 2025. The company expanded its facilities and increased inpatient capacity, despite competition in the market. While HCA shows promise as an investment, alternative AI stocks may offer better potential for returns.
Source: YAHOO